Exclusive Interview with GSK released ahead of Pharmaceutical Microbiology USA

Monday, March 20, 2017 Drug News
Email Print This Page Comment
SMi's Pharmaceutical Microbiology USA will take place in San Diego on the 8th and 9th of June 2017

SAN DIEGO, March 20, 2017 /PRNewswire/ -- After the success of SMi's Pharmaceutical Microbiology UK shows, the 7th in

its series will launch stateside in California. The US programme will provide attendees with the latest updates in the pharmaceutical microbiology field from industry leading experts through a series of presentations, an extended training session and two pre-conference workshops. Topics that will be discussed include environmental monitoring, sterility assurance, endotoxin recovery, rapid microbial methods, data integrity and biofilms.

In the lead up to the event, SMi Group caught up with the chairman of day one and featured speaker Donald Singer, GSK Fellow, Steriles Microbiology, R&D from GSK for a quick Q & A session.

Donald will be providing the opening address on day one of the conference with his presentation entitled 'Retracing the path to sterility assurance: A USP journey'. He will touch upon: Updates on the latest revisions of USP microbiology chapters; work activities for revising chapters on sterility assurance and current thinking about sterile product evaluation topics (bacterial endotoxins testing, alternative pyrogen test, container closure integrity evaluation, sterility test).

Q&A snapshot:

"SMi:  What do you believe are the biggest challenges for you?

DS: Finding good placement of the new analytical technologies so that they provide value to our company, and developing sustainable knowledge in our company as it progresses through ongoing change and the industry compliance requirements increase."

For the full Q&A session, visit the download centre of the event website.

Running alongside the conference will be two pre-conference workshops held on the 7th of June.

WORKSHOP A: Technologies for Monitoring Contamination Control and Case Studies on Contamination Control. Hosted by Jim Polarine Jr., Senior Technical Service Manager, STERIS Corporation and Andrew Bartko, Research Leader, Battelle Memorial Institute.

WORKSHOP B: Microbial Required Use for Terminal Sterilization. Hosted by Jerry Dalfors, Principal, JD Technologies.

For those wanting to attend, there is currently an early bird offer available; book by the 31st of March to save $200 off the conference price. Register at www.pharma-microbiology-usa.com.

Pharmaceutical Microbiology USA is sponsored by Charles River, Rapid Microbiosytems and Biomerieux.

For sponsorship packages: Contact Alia Malick +44 (0) 207 827 6168 or e-mail amalick@smi-online.co.uk.

For delegate enquiries: Contact Fateja Begum on +44 (0) 20 7827 6184 or email fbegum@smi-online.co.uk.

For media enquiries, contact Zoe Gale on +44 (0) 20 7827 6138 or zgale@smi-online.co.uk.

Photo(s):https://www.prlog.org/12627525

Press release distributed by PRLog

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/exclusive-interview-with-gsk-released-ahead-of-pharmaceutical-microbiology-usa-300426254.html

SOURCE SMi Group



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook